ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,347Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 434

$810K Total Retail Price of All Prescriptions

Rank: 10 out of 434

880 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 880 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 880 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 17,678 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
OMEPRAZOLE 1,050 890 1 5
SIMVASTATIN 1,037 999 2 2
LEVOTHYROXINE SODIUM 1,017 916 3 3
LISINOPRIL 1,000 892 4 1
HYDROCODONE-ACETAMINOPHEN 893 771 S3 5 4
ALENDRONATE SODIUM 571 544 6 15
AMLODIPINE BESYLATE 507 481 7 6
PRAVASTATIN SODIUM 382 336 8 17
ATENOLOL 364 305 9 16
METFORMIN HCL 361 343 10 7
HYDROCHLOROTHIAZIDE 356 322 11 8
FUROSEMIDE 332 288 12 9
WARFARIN SODIUM 330 302 13 18
SERTRALINE HCL 323 274 14 27
ZOLPIDEM TARTRATE 317 276 15 11
LOSARTAN POTASSIUM 280 252 16 13
GABAPENTIN 267 228 17 14
LOVASTATIN 265 230 18 10
VENTOLIN HFA 255 213 19 30
METOPROLOL TARTRATE 254 243 20 12
POTASSIUM CHLORIDE 248 212 21 20
MELOXICAM 239 207 22 46
FLUTICASONE PROPIONATE 206 174 23 26
CITALOPRAM HBR 192 156 24 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 155 25 21
RANITIDINE HCL 188 175 26 31
METOPROLOL SUCCINATE 187 161 27 22
ALLOPURINOL 181 164 28 25
TRIAMTERENE-HCTZ 181 178 28 47
GLIPIZIDE ER 180 165 30 65
METFORMIN HCL ER 169 143 31 48
ATORVASTATIN CALCIUM 139 126 32 19
CLOPIDOGREL 134 122 33 41
FENOFIBRATE 132 97 34 43
TRAZODONE HCL 132 91 34 33
CARVEDILOL 129 109 36 24
TAMSULOSIN HCL 128 128 37 29
OXYCODONE HCL 118 33 S2 38 34
DIGOXIN 116 109 39 69
GLYBURIDE 115 103 R 40 51
LOSARTAN-HYDROCHLOROTHIAZIDE 110 110 41 39
OXYBUTYNIN CHLORIDE 109 89 42 82
TRAMADOL HCL 107 88 43 28
AMITRIPTYLINE HCL 107 87 R 43 57
FLUOXETINE HCL 104 79 45 32
CYMBALTA 103 83 46 109
PLAVIX 99 87 47 64
BUPROPION XL 99 93 47 227
TERAZOSIN HCL 98 95 49 40
POLYETHYLENE GLYCOL 3350 98 86 49 81
FINASTERIDE 97 97 51 54
GLIPIZIDE 93 90 52 37
OXYBUTYNIN CHLORIDE ER 92 92 53 91
ISOSORBIDE MONONITRATE ER 91 86 54 68
OXYCODONE HCL-ACETAMINOPHEN 90 52 S2 55 53
DONEPEZIL HCL 88 85 56 35
MORPHINE SULFATE ER 86 64 S2 57 50
DILTIAZEM 24HR ER 85 78 58 103
BENAZEPRIL HCL 85 73 58 49
DICLOFENAC POTASSIUM 84 78 60 236
LANTUS SOLOSTAR 83 75 61 71
CLONIDINE HCL 80 56 62 63
NAPROXEN 79 77 63 75
DICLOFENAC SODIUM 76 51 64 92
CYCLOBENZAPRINE HCL 76 26 R 64 101
PEN NEEDLE 74 68 66 83
TRIAMTERENE-HYDROCHLOROTHIAZID 73 53 67 191
OXYCODONE-ACETAMINOPHEN 67 65 S2 68 74
SPIRIVA 66 53 69 36
KLOR-CON 10 66 62 69 116
DILTIAZEM ER 64 57 71 98
BENICAR 61 61 72 121
SYMBICORT 59 59 73 93
INSULIN SYRINGE 58 45 74 120
TIZANIDINE HCL 57 38 75 88
NIFEDIPINE ER 56 54 76 86
ACTOS 54 52 77 85
KLOR-CON M20 54 54 77 142
IBUPROFEN 52 36 79 56
SUMATRIPTAN SUCCINATE 50 32 80 226
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.